| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| FATE THERAPEUTICS INC | Chief Commercial Officer | Stock Option (Right to Buy) | 425K | $1.16M | $2.73 | Feb 6, 2023 | Direct |
| Kura Oncology, Inc. | Chief Commercial Officer | Common Stock | 59.7K | $470K | $7.87 | Jan 28, 2025 | Direct |
| FATE THERAPEUTICS INC | Chief Commercial Officer | Common Stock | 41.1K | $180K | $4.37 | Jul 5, 2023 | Direct |
| Kura Oncology, Inc. | Chief Commercial Officer | Option to purchase common stock | 92.5K | Jan 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KURA | Kura Oncology, Inc. | Jan 28, 2025 | 1 | -$12.5K | 4 | Jan 28, 2025 | Chief Commercial Officer |
| KURA | Kura Oncology, Inc. | Jan 2, 2025 | 2 | $0 | 4 | Jan 6, 2025 | Chief Commercial Officer |
| KURA | Kura Oncology, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Chief Commercial Officer |
| KURA | Kura Oncology, Inc. | Aug 14, 2023 | 1 | $0 | 4 | Aug 16, 2023 | Chief Commercial Officer |
| KURA | Kura Oncology, Inc. | Aug 14, 2023 | 0 | $0 | 3 | Aug 16, 2023 | Chief Commercial Officer |
| FATE | FATE THERAPEUTICS INC | Jul 5, 2023 | 1 | -$18.8K | 4 | Jul 6, 2023 | Chief Commercial Officer |
| FATE | FATE THERAPEUTICS INC | Feb 6, 2023 | 1 | $0 | 4 | Feb 7, 2023 | Chief Commercial Officer |
| FATE | FATE THERAPEUTICS INC | Jun 27, 2022 | 2 | $0 | 4 | Jun 29, 2022 | Chief Commercial Officer |
| FATE | FATE THERAPEUTICS INC | Jun 27, 2022 | 0 | $0 | 3 | Jun 29, 2022 | Chief Commercial Officer |